- Home
- ABLLW vs TECH Comparison
ABLLW vs TECH Comparison
Compare ABLLW & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABLLW
- TECH
- Stock Information
- Founded
- ABLLW 2004
- TECH 1976
- Country
- ABLLW United States
- TECH United States
- Employees
- ABLLW 125
- TECH N/A
- Industry
- ABLLW Investment Managers
- TECH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ABLLW Finance
- TECH Health Care
- Exchange
- ABLLW Nasdaq
- TECH Nasdaq
- Market Cap
- ABLLW N/A
- TECH 7.9B
- IPO Year
- ABLLW N/A
- TECH 1989
- Fundamental
- Price
- ABLLW $1.69
- TECH $49.78
- Analyst Decision
- ABLLW
- TECH Buy
- Analyst Count
- ABLLW 0
- TECH 9
- Target Price
- ABLLW N/A
- TECH $73.88
- AVG Volume (30 Days)
- ABLLW 51.3K
- TECH 2.1M
- Earning Date
- ABLLW 03-21-2025
- TECH 05-07-2025
- Dividend Yield
- ABLLW N/A
- TECH 0.64%
- EPS Growth
- ABLLW N/A
- TECH N/A
- EPS
- ABLLW N/A
- TECH 0.83
- Revenue
- ABLLW $102,407,324.00
- TECH $1,208,770,000.00
- Revenue This Year
- ABLLW N/A
- TECH $8.19
- Revenue Next Year
- ABLLW N/A
- TECH $8.61
- P/E Ratio
- ABLLW N/A
- TECH $59.98
- Revenue Growth
- ABLLW 77.68
- TECH 4.72
- 52 Week Low
- ABLLW $1.02
- TECH $46.44
- 52 Week High
- ABLLW $1.05
- TECH $85.57
- Technical
- Relative Strength Index (RSI)
- ABLLW N/A
- TECH 43.61
- Support Level
- ABLLW N/A
- TECH $46.77
- Resistance Level
- ABLLW N/A
- TECH $51.54
- Average True Range (ATR)
- ABLLW 0.00
- TECH 2.08
- MACD
- ABLLW 0.00
- TECH 0.36
- Stochastic Oscillator
- ABLLW 0.00
- TECH 50.07
About ABLLW Abacus Life Inc.
Abacus Global Management Inc is a financial services company specializing in alternative asset management, data-driven wealth solutions, technology innovations, and institutional services. The Company organizes its business into five reportable segments Active Management, Originations, Asset Management, Portfolio Servicing, and Technology Services. Its operations are confined to the United States.
About TECH Bio-Techne Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.